NEWSpublisher 2007 :: AngloChinese Investments
SEARCH NEWS
date from:
date to:
company:
search for string:
NEWS SECTIONS
COMPANY GROUPS
TOP NEWS
» 23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products
» 15/03/2010 [Industry news]
Recordati S.p.A And Lee Pharmaceutical Announce Partnership For Zanidip(R) In China
» 26/10/2009 [Finance]
China Growth to Remain Fast in Fourth Quarter, Official Says
» 17/08/2009 [Industry news]
Chindex Posts Profit on Product Sales, Health Services
» 07/05/2010 [Industry news]
Hong Kong: Recall of all products manufactured by Quality Pharmaceutical Lab Ltd
COMPANY NEWS » TOP China Pharmas  «  1  2  3  4  5  » 
found files: 128
3SBIO (Shenyang Sunshine) »05/05/2009 [Company watch]
3SBio Inc. Announces Appointment of Ernst & Young Hua Ming as Independent Auditor

3SBio Inc. a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced the appointment of Ernst & Young Hua Ming as the Company\'s independent registered public accounting firm....   more»


China Biopharmaceuticals Holdings »30/04/2009 [Industry news]
China Pharma Holdings, Inc. (CPHI.OB) Appoints Chief Financial Officer and Board Member

China Pharma Holdings, Inc. which develops, manufactures, and markets specialty pharmaceutical products in China, today announced that it has appointed Mr. Frank Waung to Chief Financial Officer, and has nominated Ms. Heung Mei Tsui to the Board of Directors....   more»


Simcere Pharmaceutical Group »07/05/2009 [Company watch]
Simcere seeks to manufacture Zanamivir

Simcere Pharmaceutical, a manufacturer and supplier of branded generic and innovative anti-cancer pharmaceuticals in China, has announced that the company is seeking approval to manufacture and sell products containing Zanamivir....   more»


China Sky One Medical,Inc. »15/05/2009 [Company watch]
First Quarter Results

Revenues double and GP up almost 100%...   more»


China Biopharmaceuticals Holdings »15/05/2009
China Pharma Holdings, Inc. (CPHI.OB) Reports First Quarter 2009 Financial Results and Corporate Updates

China Pharma Holdings, which develops, manufactures, and markets specialty pharmaceutical products in China, today announced financial results for the first quarter ended March 31, 2009....   more»


China Sky One Medical,Inc. »21/05/2009 [Industry news]
China Sky One Medical, Signs Agreement with Taiwan Golden Biotechnology Corporation on Development of New Anti-Cancer Drug

China Sky One Medical, today announced that it signed an agreement with Taiwan Golden Biotechnology Corporation to begin cooperating on the development of a new anti-cancer drug called Antroquinonol....   more»


China Sky One Medical,Inc. »03/06/2009 [Company watch]
China Sky One Medical, Obtains SFDA Approval

China Sky One Medical, today announced that it obtained approval from the (SFDA) in China for the production of Diclofenac Sodium eye drops. The document number for the drug is 2009S02063....   more»


China Biopharmaceuticals Holdings »24/06/2009 [Company watch]
China Pharma Wins OK for Generic Cholesterol Drug Trials

China Pharma Holdings (CPHI.OB) obtained approval from the SFDA to begin Phase I and Phase II clinical trials of Rosuvastatin...   more»


China Sky One Medical,Inc. »14/07/2009 [Company watch]
China Sky One Medical, Inc. Obtains Renewal of GMP Certificate

The company today announced that its Peng Lai Jin Chuang Pharmaceutical Company subsidiary obtained a renewal of its Good Manufacturing Practices Certificate for Pharmaceutical Products (GMP)...   more»


China Aoxing Pharmaceutical Company, Inc. »23/07/2009 [Company watch]
China Aoxing Pharmaceutical Corp. Receives Renewal of GMP Certification for Capsule Dosage Form of Pharmaceutical Products

China Aoxing Pharmaceutical Company, Inc., a China-based pharmaceutical company specializing in research, development, manufacturing and distribution of narcotic and pain-management products, today announced that it has received renewal of the Good Manufacturing Practice (GMP) certification for its capsule formulation and packaging production facility....   more»


Lotus Pharmaceuticals »31/07/2009 [Company watch]
Lotus Receives Diabetes Drug Patent

Lotus Pharmaceuticals has received a patent pending notice from China Intellectual Property Office for Gliclazide-Controlled Release Tablets, a controlled release form of the hypoglycemic drug gliclazide that is aimed at type 2 diabetes....   more»


China Aoxing Pharmaceutical Company, Inc. »07/08/2009
China Aoxing Pharmaceutical Corp. (CAXG) Announces Completion of $5 Million Private Placement of Common Stock

China Aoxing Pharmaceutical Company, Inc.a pharmaceutical company specializing in research, development, manufacturing and marketing of narcotic and pain-management products, today announced that it has completed a private placement with a total of fifteen institutional and other accredited investors of 5,263,158 shares of the Companys common stock at a purchase price of $0.95 per share, for gross proceeds of $5 million....   more»


China Sky One Medical,Inc. »06/08/2009 [Company watch]
China Sky One Medical, Inc. Appoints New Independent Director

China Sky One Medical, today announced the appointment of Mr. William Wei Lee as an independent member of the Company Board of Directors effective August 4, 2009. Mr. Jiang Qi-Feng resigned from the Board effective August 4, 2009. Following this appointment, China Sky One Medicals Board of Directors has seven members, four of whom are independent....   more»


China Aoxing Pharmaceutical Company, Inc. »12/08/2009 [Company watch]
China Aoxing Alleviates Liquidity Needs with Sale of 5.2 Million Shares

China Aoxing Pharmaceutical Company raised $5 million by selling 5.2 million shares at a price of $.95 each. The sale was made without an agent to fifteen institutional and other accredited investors....   more»


China Biopharmaceuticals Holdings »12/08/2009 [Company watch]
China Pharma Holdings, Inc. Reports Second Quarter 2009 Financial Results

China Pharma Holdings, Inc. Reports Second Quarter 2009 Financial Results and Corporate Updates Revenue Increases 20.6% Year Over Year to $13.6 Million...   more»


China Biopharmaceuticals Holdings »18/08/2009 [Company watch]
China Pharma Holdings, Inc. Announces SFDA Approval for Production of Omeprazole Injections

Omeprazole is widely utilized to treat gastroesophageal reflux disease (GERD), and is highly effective in other conditions caused by excess acidic formulations in the stomach, including gastric ulcers, recurrent duodenal ulcers and Zollinger-Ellison Syndrome....   more»


Simcere Pharmaceutical Group »21/08/2009 [Industry news]
Forty-two of Simcere Pharmaceutical Group Generic Drugs Enter the China Essential Drug List

Simcere Pharmaceutical Group a leading manufacturer and supplier of branded generic and innovative pharmaceuticals in China, today announced that forty-two of its generic drugs have been included in China\'s Essential Drug List, which was issued by China Ministry of Health on August 18, 2009....   more»


Simcere Pharmaceutical Group »25/09/2009 [Company watch]
Simcere Teams Up with Cancer Centre to Develop Drugs

Simcere Pharmaceutical Group and Sun Yat-Sen University Cancer Center of Guangzhou have established a strategic relationship to develop cancer drugs....   more»


China Sky One Medical,Inc. »30/08/2009 [Company watch]
China Sky One Admits Under-Reported Revenue

China Sky One Medical admitted that its financial reports filed with the State Administration for Industry and Commerce (SAIC) under-reported the income of China Sky One China-based subsidiaries....   more»


China Aoxing Pharmaceutical Company, Inc. »17/09/2009 [Company watch]
China Aoxing Receives SFDA Approval for Clinical Trial of Abuse Resistant Opioid Drug

China Aoxing, today announced that its Clinical Trial Application for Tilidine/Naloxone Capsules, an opioid drug with abuse resistance property, was officially approved by the China State Food and Drug Administration. CTA approval is a key SFDA requirement prior to pursuing a clinical trial...   more»

AngloChinese Investments ltd.
Home | Company news | TOP 50 | Events | About us
C&F Bright Solutions ltd.